Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
3-Jun-2020
Expiry of options
27-May-2020
Appendix 3Y Iain Ross
26-May-2020
Appendix 2A conversion of options
11-May-2020
Change of Director's Interest Notice x4
8-May-2020
Kazia Appendix 2A
8-May-2020
Change in substantial holding
6-May-2020
Kazia Share Purchase Plan raises $1.8m
1-May-2020
Kazia Share Purchase Plan extended
29-Apr-2020
Kazia Share Purchase Plan reminder
22-Apr-2020
Becoming a substantial holder
Previous
1
2
3
4
5
6
7
8
9
10
11
Next
